<SEC-DOCUMENT>0001213900-23-050034.txt : 20230620
<SEC-HEADER>0001213900-23-050034.hdr.sgml : 20230620
<ACCEPTANCE-DATETIME>20230620160534
ACCESSION NUMBER:		0001213900-23-050034
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230620
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230620
DATE AS OF CHANGE:		20230620

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Citius Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001506251
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				273425913
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38174
		FILM NUMBER:		231025040

	BUSINESS ADDRESS:	
		STREET 1:		11 COMMERCE DRIVE
		STREET 2:		1ST FLOOR
		CITY:			CRANFORD
		STATE:			NJ
		ZIP:			07016
		BUSINESS PHONE:		(908) 967-6676

	MAIL ADDRESS:	
		STREET 1:		11 COMMERCE DRIVE
		STREET 2:		1ST FLOOR
		CITY:			CRANFORD
		STATE:			NJ
		ZIP:			07016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Trail One, Inc.
		DATE OF NAME CHANGE:	20110314

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TrailOne, Inc.
		DATE OF NAME CHANGE:	20101119
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea180605-8k_citiuspharma.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:CTXR="http://citiuspharma.com/20230620">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_CTXR_citiuspharma.com_20230620 -->
<!-- Field: Set; Name: xdx; ID: xdx_040_20230620_20230620 -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DEntityCentralIndexKey_0001506251 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-06-20to2023-06-20" name="dei:EntityCentralIndexKey">0001506251</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-06-20to2023-06-20" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="ctxr-20230620.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-06-20to2023-06-20">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506251</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-20</xbrli:startDate>
        <xbrli:endDate>2023-06-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">UNITED
STATES</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECURITIES
AND EXCHANGE COMMISSION</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Washington,
D.C. 20549</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORM
<span id="xdx_901_edei--DocumentType_c20230620__20230620_zZJfoW0kPIqj"><ix:nonNumeric contextRef="From2023-06-20to2023-06-20" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CURRENT
REPORT</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 13 or 15(d) of</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Securities Exchange Act of 1934</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported) <span style="text-decoration: underline"><span id="xdx_90B_edei--DocumentPeriodEndDate_c20230620__20230620_z7aIWRxV5eLi"><ix:nonNumeric contextRef="From2023-06-20to2023-06-20" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">June 20, 2023</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_909_edei--EntityRegistrantName_c20230620__20230620_zkSwNLiCYPMh"><ix:nonNumeric contextRef="From2023-06-20to2023-06-20" name="dei:EntityRegistrantName">Citius
Pharmaceuticals, Inc.</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_90D_edei--EntityIncorporationStateCountryCode_c20230620__20230620_z2Zl7gOGZJBl"><ix:nonNumeric contextRef="From2023-06-20to2023-06-20" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
or other jurisdiction of incorporation)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--EntityFileNumber_c20230620__20230620_zRAb7AGrWdgc"><ix:nonNumeric contextRef="From2023-06-20to2023-06-20" name="dei:EntityFileNumber">001-38174</ix:nonNumeric></span></span></td>
    <td style="padding-bottom: 1.5pt; text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--EntityTaxIdentificationNumber_c20230620__20230620_zfcyUI602f4k"><ix:nonNumeric contextRef="From2023-06-20to2023-06-20" name="dei:EntityTaxIdentificationNumber">27-3425913</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission File Number)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS Employer Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--EntityAddressAddressLine1_c20230620__20230620_zVGjiq043fDg"><ix:nonNumeric contextRef="From2023-06-20to2023-06-20" name="dei:EntityAddressAddressLine1">11 Commerce Drive</ix:nonNumeric></span>, <span id="xdx_90E_edei--EntityAddressAddressLine2_c20230620__20230620_zSXLuUlWPAt9"><ix:nonNumeric contextRef="From2023-06-20to2023-06-20" name="dei:EntityAddressAddressLine2">1st Floor</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressCityOrTown_c20230620__20230620_ziZDKvEczJJh"><ix:nonNumeric contextRef="From2023-06-20to2023-06-20" name="dei:EntityAddressCityOrTown">Cranford</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressStateOrProvince_c20230620__20230620_zlZvIGLNzWc1"><ix:nonNumeric contextRef="From2023-06-20to2023-06-20" name="dei:EntityAddressStateOrProvince">NJ</ix:nonNumeric></span></span></td>
    <td style="padding-bottom: 1.5pt; text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--EntityAddressPostalZipCode_c20230620__20230620_zu0OLwo9O9Af"><ix:nonNumeric contextRef="From2023-06-20to2023-06-20" name="dei:EntityAddressPostalZipCode">07016</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address of principal executive offices)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant's
telephone number, including area code <span style="text-decoration: underline">(<span id="xdx_908_edei--CityAreaCode_c20230620__20230620_zeYUwYTCfTfl"><ix:nonNumeric contextRef="From2023-06-20to2023-06-20" name="dei:CityAreaCode">908</ix:nonNumeric></span>) <span id="xdx_900_edei--LocalPhoneNumber_c20230620__20230620_zaqG3N0kl5z7"><ix:nonNumeric contextRef="From2023-06-20to2023-06-20" name="dei:LocalPhoneNumber">967-6677</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span id="xdx_90F_edei--WrittenCommunications_c20230620__20230620_zVOxFjpmHiO6"><ix:nonNumeric contextRef="From2023-06-20to2023-06-20" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Wingdings 2"></span><span id="xdx_909_edei--SolicitingMaterial_c20230620__20230620_zgi6j1VRIBX"><ix:nonNumeric contextRef="From2023-06-20to2023-06-20" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Wingdings 2"></span><span id="xdx_90D_edei--PreCommencementTenderOffer_c20230620__20230620_zIiiKUaIek5k"><ix:nonNumeric contextRef="From2023-06-20to2023-06-20" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="vertical-align: top">
    <td><span id="xdx_90F_edei--PreCommencementIssuerTenderOffer_c20230620__20230620_zNvcdOmZywV7"><ix:nonNumeric contextRef="From2023-06-20to2023-06-20" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></p></td>
    <td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol(s)</span></p></td>
    <td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of each exchange<br />
on which registered</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--Security12bTitle_c20230620__20230620_zAv7B4OFY8B2"><ix:nonNumeric contextRef="From2023-06-20to2023-06-20" name="dei:Security12bTitle">Common
    stock, $0.001 par value</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--TradingSymbol_c20230620__20230620_zsfSZ90OKtRf"><ix:nonNumeric contextRef="From2023-06-20to2023-06-20" name="dei:TradingSymbol">CTXR</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    <span id="xdx_90A_edei--SecurityExchangeName_c20230620__20230620_zuwuP7IgwJZ9"><ix:nonNumeric contextRef="From2023-06-20to2023-06-20" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_908_edei--EntityEmergingGrowthCompany_c20230620__20230620_z7JwUCMdOEO8"><ix:nonNumeric contextRef="From2023-06-20to2023-06-20" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
8.01 Other Events.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 20, 2023, Citius Pharmaceuticals, Inc. issued a press release to announce positive results from the Phase 2b Study of Halo-Lido
for the treatment of hemorrhoids. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01. Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#160;<span style="text-decoration: underline">Exhibits</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following exhibit is filed herewith:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 89%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea180605ex99-1_citiuspharma.htm">Press Release dated June 20, 2023.</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="white-space: nowrap">104</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">Cover Page Interactive Date File (embedded within the Inline XBRL document).</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURE</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%; text-align: justify">&#160;</td>
    <td style="width: 35%; text-align: justify">&#160;</td>
    <td style="width: 20%">&#160;</td>
    <td style="width: 40%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CITIUS PHARMACEUTICALS, INC.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 20, 2023</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Leonard Mazur</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leonard Mazur</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman and Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">2</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwjAQhE/QOyx5lppW/KFvWrSIVaSI+BrtKsE2Wzbx70je0tgiLgvLMvPNCNETGS10hQyHWZHDDuumUg6hwDMymhN6R7pcJeBvgRdtHSvj2vcHpuQZ9MwwjCZHL7TWu7ZYJiBH/Vj24wHISSLHMF2L4KunZM66ROO0qkCZErZMDWt0il9dwk49yVD9aqv2yFaTSSAKZSe/IZZRDBu6qwfx1UKepyLotROIjOnWfGtu1lEN8wpr32U79L/BBxUrSUM= -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea180605ex99-1_citiuspharma.htm
<DESCRIPTION>PRESS RELEASE DATED JUNE 20, 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Citius Pharmaceuticals
Announces Positive Results from the Phase 2b Study of Halo-Lido (CITI-002) for the Treatment of Hemorrhoids</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>CITI-002 provides a meaningful reduction in
symptom severity when compared to individual components alone</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Dose for Phase 3 trial selected; Citius to schedule
end of Phase 2 meeting with the FDA</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Trial validates Patient Reported Outcome (PRO)
instrument developed to support a pivotal Phase 3 study </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>CRANFORD, N.J.</B>, June 20, 2023 -- Citius
Pharmaceuticals, Inc. (&ldquo;Citius&rdquo; or the &ldquo;Company&rdquo;) (Nasdaq: CTXR) today announced results from the Company&rsquo;s
Phase 2b clinical study of Halo-Lido (CITI-002), a topical formulation for the relief of hemorrhoid symptoms. This trial was designed
to assess the efficacy of the combination product, select the appropriate dose and endpoints for a Phase 3 trial and to validate the PRO.
The high dose formulation of CITI-002, a lidocaine and halobetasol propionate combination formulation, provided a meaningful reduction
in symptom severity, as reported by patients, when compared to individual components alone. Moreover, there were no reported significant
adverse events and CITI-002 was well tolerated by patients in the study. Citius intends to schedule an end of Phase 2 meeting with the
U.S Food and Drug Administration (FDA) to begin planning the next steps in the regulatory and clinical development program for CITI-002.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>CITI-002 Phase 2b Trial Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Approximately
300 adults with a clinical diagnosis of symptomatic hemorrhoids were enrolled in the Halo-Lido Phase 2b study (</FONT>NCT05348200<FONT STYLE="font-family: Times New Roman, Times, Serif">),
a multi-center, randomized, dose-ranging, double-blind, parallel group comparison clinical trial. The study assessed a high dose (CITI-002H)
and low dose (CITI-002L) formulation of the combination drug products in comparison to the single active drug monads: high dose halobetasol,
low dose halobetasol and lidocaine. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="background-color: white">Recently,
there has been a shift from the use of traditional clinical analysis and outcomes to patients&rsquo; perspectives and patients&rsquo; experiences
in assessing treatment efficacy. Following the 21<SUP>st</SUP> Century Cures Act, higher emphasis is placed on using Patient Reported
Outcome (PRO) instruments in clinical trials. Currently, for hemorrhoidal disease, there are </FONT>no validated clinical outcomes assessment
(COA) tools available in the US. The FDA directed Citius to develop a &ldquo;fit for purpose&rdquo; PRO instrument to assess the efficacy
of treatments in this disease. Symptom intensity and impact data (Hemorrhoid Quality of Life Index or HQLI) were recorded by patients
utilizing a proprietary mobile-enabled Patient Reported Outcome (PRO) instrument developed by Citius for this study.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Data collected using the Hemorrhoid Quality of
Life Index (HQLI) was analyzed to derive a meaningful change threshold (MCT) to&nbsp;test for the change in hemorrhoidal symptoms considered
relevant to the patient during and following treatment.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>CITI-002 Phase 2b Trial Results </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Treatment effect on hemorrhoidal symptoms was
analyzed using the MCT. At the end of the 7-day treatment period, 42% of the patients in the high dose CITI-002 (CITI-002H) group reached
MCT compared to patients treated with high dose halobetasol alone (29%) or patients treated with lidocaine alone (21%).&nbsp; Moreover,
proportionally more patients in the CITI-002H cohort reported meaningful and statistically significant improvement as compared to patients
treated with lidocaine alone (<I>CMH test, p = 0.035</I>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">We additionally assessed clinical treatment efficacy
outcomes during 7-day treatment and 7-day follow-up periods using an analysis of covariance, which analyzed changes from baseline. Substantial
improvements were seen across all active treatment groups. Although no statistical significance was determined in the changes between
the comparison groups, directionally the data signaled that the combination products provided faster relief compared to individual monads,
and the relief persisted after completing treatment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">In addition, results from the study indicated
that there were no material clinical safety concerns across the five active treatment groups during the 7-day treatment or follow-up periods.&nbsp;
There were no serious adverse events reported.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Data from the Phase 2b trial confirmed that the
HQLI is appropriate to measure patient-reported changes in hemorrhoidal symptoms. Consequently, Citius believes the instrument can be
used in future Phase 3 trial development. Citius is actively pursuing intellectual property protections for its groundbreaking work in
developing the fit for purpose PRO instrument and has filed patent applications on its CITI-002 formulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Based on the positive clinical results utilizing
the Meaningful Change Threshold analysis, Citius plans to present this data at the end of Phase 2 meeting with the FDA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&ldquo;We are extremely pleased that we met several
key objectives with this Phase 2b trial. Moreover, we have identified an endpoint for meaningful symptom relief utilizing a combination
product, selected a dose for a Phase 3 trial, and robustly validated our proprietary PRO as a data collection tool for the next study.
The trial showed that proportionately more patients experienced symptom relief with high dose CITI-002 than patients treated with lidocaine
or halobetasol alone. With its excellent safety profile and ease of administration for patients as a topical cream, we believe CITI-002
could be an important advancement in the treatment of hemorrhoids. Our preference is to seek a development partner to further advance
CITI-002; we plan to initiate that process after determining our next steps in the development of CITI-002,&rdquo; stated Mr. Leonard
Mazur, Chairman and CEO of Citius.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&ldquo;To solidify our intellectual property position,
we will continue to expand our patent portfolio with pending patent applications for both the formulation and the proprietary assessment
of hemorrhoid treatment using PROs. We expect this will support a compelling competitive advantage through 2044, should CITI-002 gain
approval in the future,&rdquo; added Mr. Mazur.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Dr. Myron Czuczman, Chief Medical Officer of Citius
stated, &ldquo;The encouraging Phase 2b results indicate that CITI-002 may have the potential to provide patients with relief from the
pain and discomfort associated with hemorrhoids. As far as we know, this is the first study of its kind, utilizing a novel PRO, conducted
in hemorrhoid patients. We now better understand how to design the pivotal Phase 3 study with relevant end points and look forward to
further use of our proprietary PRO tool to evaluate efficacy. Moreover, the current results reinforce our confidence in the safety and
tolerability of CITI-002 and strongly support further evaluation of CITI-002 in a Phase 3 study. We are looking forward to sharing the
Phase 2b data with the FDA and seeking guidance for further development of this drug.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>About Halo-Lido (CITI-002)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">CITI-002 is a proprietary topical formulation
intended to provide symptomatic relief to individuals suffering from hemorrhoids. Hemorrhoids are a gastrointestinal disorder characterized
by pain, swelling, itching, tenderness, and bleeding. Although hemorrhoids are not life-threatening, individual patients often suffer
painful symptoms that can limit social activities and have a negative impact on the quality of life. More than half of the U.S. population
will experience hemorrhoidal disease at least once in their life. Each year, nearly 10 million patients in the U.S. report symptoms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>About Citius Pharmaceuticals, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Citius is a late-stage biopharmaceutical company
dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives
in adjunct cancer care, unique prescription products, and stem cell therapies. The Company&rsquo;s diversified pipeline includes two late-stage
product candidates, Mino-Lok&reg;, an antibiotic lock solution for the treatment of patients with catheter-related bloodstream infections,
which is currently enrolling patients in a Phase 3 Pivotal superiority trial, and I/ONTAK (E7777), a novel IL-2R immunotherapy for an
initial indication in CTCL, for which a BLA is under review by the FDA.&nbsp; Mino-Lok&reg; was granted Fast Track designation by the
FDA. I/ONTAK has received orphan drug designation by the FDA for the treatment of CTCL and PTCL. At the end of March 2023, Citius completed
enrollment in its Phase 2b trial of CITI-002, a topical formulation for the relief of hemorrhoids. For more information, please visit
www.citiuspharma.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Safe Harbor </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
press release may contain &ldquo;forward-looking statements&rdquo; within the meaning of Section 27A of the Securities Act of 1933 and Section
21E of the Securities Exchange Act of 1934. Such statements are made based on our expectations and beliefs concerning future events impacting
Citius. You can identify these statements by the fact that they use words such as &ldquo;will,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;estimate,&rdquo;
&ldquo;expect,&rdquo; &ldquo;plan,&rdquo; &ldquo;should,&rdquo; and &ldquo;may&rdquo; and other words and terms of similar meaning or use of future
dates. Forward-looking statements are based on management&rsquo;s current expectations and are subject to risks and uncertainties that could
negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ
materially from those currently anticipated are: risks relating to the results of research and development activities, including those
from existing and new pipeline assets, including CITI-002; the estimated markets for our product candidates and the acceptance thereof
by any market; the ability of our product candidates to impact the quality of life of our target patient populations; our ability to commercialize
our products if approved by the FDA; patent and intellectual property matters; our ability to obtain, perform under and maintain financing
and strategic agreements and relationships; uncertainties relating to preclinical and clinical testing; the early stage of products under
development; our need for substantial additional funds; our dependence on third-party suppliers; our ability to procure cGMP commercial-scale
supply; market and other conditions; our ability to attract, integrate, and retain key personnel; risks related to our growth strategy;
our ability to identify, acquire, close and integrate product candidates and companies successfully and on a timely basis; government
regulation; competition; as well as other risks described in our SEC filings. These risks have been and may be further impacted by Covid-19
and could be impacted by any future public health risks. Accordingly, these forward-looking statements do not constitute guarantees of
future performance, and you are cautioned not to place undue reliance on these forward-looking statements. Risks regarding our business
are described in detail in our Securities and Exchange Commission (&ldquo;SEC&rdquo;) filings which are available on the SEC&rsquo;s website
at </FONT>www.sec.gov<FONT STYLE="font-family: Times New Roman, Times, Serif">, including in our Annual Report on Form 10-K for the year
ended September 30, 2022, filed with the SEC on December 22, 2022 and updated by our subsequent filings with the Securities and Exchange
Commission. These forward-looking statements speak only as of the date hereof, and we expressly disclaim any obligation or undertaking
to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations
or any changes in events, conditions or circumstances on which any such statement is based, except as required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ilanit Allen</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ir@citiuspharma.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">908-967-6677 x113</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Media Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">STiR-communications</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Greg Salsburg</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Greg@STiR-communications.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">4</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  S 2P# 2(  A$! Q$!_\0
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MT?1["?4]2U&Y=2S+;VEG;32285I"8RB1NS*&^>/AS^W#^R?\7/%^F^ OAO\
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M6/$BR_ ?XME94>-XW,G@?Q$K;2CL6\HJ!(54J&E0*SX<I_'Q_P $=?BEX?\
M@C^T=\5?BWXLL-?U'PY\/_V8?BAXIU>P\,:<FK^(+W2]*UKP#YS:18275G;7
M,\W_ "[1W5]9(_\ RTDBKP^%J5>.2<15\-%RJT84[\O)>G*49W;4IQNE+H[^
M:/K>/O[/GQ5P)@<7/$QP>:3J+%3YJGLU%:QYW%3:<MM(RZ,\\_;S_8L\5_\
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M_!/?]GF5(Y(T@TOQQIJ&1$52='^*WCO0DV*DD@\O_B6HT3$AC T#%4<M&O\
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MK2?=O[97['WA7]M#X1V/PD\:>)M;\*V.E^+M/\9Z?K?A]+2?4(M7T[2->T>
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M?B-<:CX0O]8O=.\.WD7AM-,FBU_P[J/A[5-,NI8=%$\FG21Z@US'&NQDEBC
M8,HDK]B7AE9B0R $\#GC_P =-?,<78K+<XSFMC\$XJG5BFW&,H>\DHO24(OW
MHJ+>F\?0^QX'RW,,KRIY7F<9PIX.IR81U7%J=)W?-'EG4LD^_+OL6Z***^9/
ML HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
?"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>ctxr-20230620.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qpZs7xRiXgen8uBYXYsWaqDiaPtyJ1xGYkxuG93fdkaPyko9xUqAyauRdI2wSgN -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:CTXR="http://citiuspharma.com/20230620" elementFormDefault="qualified" targetNamespace="http://citiuspharma.com/20230620">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://citiuspharma.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="ctxr-20230620_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="ctxr-20230620_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>ctxr-20230620_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>ctxr-20230620_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://citiuspharma.com/role/Cover" xlink:href="ctxr-20230620.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://citiuspharma.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140157689649472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 20, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 20,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38174<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Citius
Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001506251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-3425913<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">11 Commerce Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">1st Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cranford<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07016<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">908<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">967-6677<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CTXR<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>ea180605-8k_citiuspharma_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ctxr-20230620.xsd" xlink:type="simple"/>
    <context id="From2023-06-20to2023-06-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506251</identifier>
        </entity>
        <period>
            <startDate>2023-06-20</startDate>
            <endDate>2023-06-20</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-06-20to2023-06-20">0001506251</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-06-20to2023-06-20">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2023-06-20to2023-06-20">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-06-20to2023-06-20">2023-06-20</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-06-20to2023-06-20">Citius Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-06-20to2023-06-20">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-06-20to2023-06-20">001-38174</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-06-20to2023-06-20">27-3425913</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-06-20to2023-06-20">11 Commerce Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-06-20to2023-06-20">1st Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2023-06-20to2023-06-20">Cranford</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-06-20to2023-06-20">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-06-20to2023-06-20">07016</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-06-20to2023-06-20">908</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-06-20to2023-06-20">967-6677</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-06-20to2023-06-20">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-06-20to2023-06-20">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-06-20to2023-06-20">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-06-20to2023-06-20">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-06-20to2023-06-20">Common     stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-06-20to2023-06-20">CTXR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-06-20to2023-06-20">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-06-20to2023-06-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M-4H2U\7!ZQ^4ZD2HN7/08&<B+EA0BJN$7/D=<.I[.T!*1D.QD8E>I6.5Z*U
M.EK >MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*
M$3FQ!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87
M_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( +" U%8'04UB@0
M +$    0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#
M%     @ L(#45OB\9I'N    *P(  !$              ( !KP   &1O8U!R
M;W!S+V-O<F4N>&UL4$L! A0#%     @ L(#45IE<G",0!@  G"<  !,
M         ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " "P
M@-16\>@,K5P$   =$0  &               @($-"   >&PO=V]R:W-H965T
M<R]S:&5E=#$N>&UL4$L! A0#%     @ L(#45I^@&_"Q @  X@P   T
M         ( !GPP  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " "P@-16EXJ[
M',     3 @  "P              @ %[#P  7W)E;',O+G)E;'-02P$"% ,4
M    " "P@-16JL0B%C,!   B @  #P              @ %D$   >&PO=V]R
M:V)O;VLN>&UL4$L! A0#%     @ L(#45B0>FZ*M    ^ $  !H
M     ( !Q!$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%
M  @ L(#45F60>9(9 0  SP,  !,              ( !J1(  %M#;VYT96YT
A7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  \Q,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea180605-8k_citiuspharma.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://citiuspharma.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ea180605-8k_citiuspharma.htm">ea180605-8k_citiuspharma.htm</File>
    <File>ctxr-20230620.xsd</File>
    <File>ctxr-20230620_lab.xml</File>
    <File>ctxr-20230620_pre.xml</File>
    <File>ea180605ex99-1_citiuspharma.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ea180605-8k_citiuspharma.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "ea180605-8k_citiuspharma.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ctxr-20230620_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ctxr-20230620_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ctxr-20230620.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "CTXR",
   "nsuri": "http://citiuspharma.com/20230620",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea180605-8k_citiuspharma.htm",
      "contextRef": "From2023-06-20to2023-06-20",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://citiuspharma.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea180605-8k_citiuspharma.htm",
      "contextRef": "From2023-06-20to2023-06-20",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://citiuspharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001213900-23-050034-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-23-050034-xbrl.zip
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M:*6>$2NK0+^I2E!>B^WWR^N;KN4GN5EODG^M<$KDEO\"4$L#!!0    ( +"
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MKZ2\SUD 8$"8W-@#+H Z!&7G?:[/6<RYJMRLT8Q*^/@H90M?XC<64QN@A&S
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M   1              "  0    !C='AR+3(P,C,P-C(P+GAS9%!+ 0(4 Q0
M   ( +" U%8M&F%+_@H  ("&   5              "  5H#  !C='AR+3(P
M,C,P-C(P7VQA8BYX;6Q02P$"% ,4    " "P@-16L IL>5H'  #=5P  %0
M            @ &+#@  8W1X<BTR,#(S,#8R,%]P<F4N>&UL4$L! A0#%
M  @ L(#45C"&"Y\9$@  0X,  !P              ( !&!8  &5A,3@P-C U
M+3AK7V-I=&EU<W!H87)M82YH=&U02P$"% ,4    " "P@-16":&<(_\5  #$
M4@  'P              @ %K*   96$Q.# V,#5E>#DY+3%?8VET:75S<&AA
=<FUA+FAT;5!+!08     !0 % %P!  "G/@     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
